INTERNATIONAL PATENT: YANTAI LANNACHENG BIOTECHNOLOGY CO., LTD., 烟台蓝纳成生物技术有限公司 FILES APPLICATION FOR "METHOD FOR TREATING THYROID CANCER BY USING FIBROBLAST ACTIVATION PROTEIN INHIBITOR MODIFIED WITH RADIOLABELED TRUNCATED EVANS BLUE"

GENEVA, May 10 -- YANTAI LANNACHENG BIOTECHNOLOGY CO., LTD. (Room 101, Building 52, No. 500 Binhai East Road, Muping DistrictYantai, Shandong 264199), 烟台蓝纳成生物技术有限公司 (中国山东省烟台市牟平区滨海东路500号52号楼101号) filed a patent application (PCT/CN2023/127468) for "METHOD FOR TREATING THYROID CANCER BY USING FIBROBLAST ACTIVATION PROTEIN INHIBITOR MODIFIED WITH RADIOLABELED TRUNCATED EVANS BLUE" on Oct 30, 2023. With publication no. WO/2025/091141, the details related to the patent application was published on May 08, 2025.

Notably, the p...